Reid Hoffman to leave Microsoft board to focus on AI drug discovery startup Manas AI
AI summary
Hoffman's shift from Microsoft's board to AI drug discovery highlights a growing trend of tech leaders prioritizing health innovation.
Why selected · Evaluation
AI rationale
关注 AI 药物发现赛道
Dimensions: AI value rating (grounded in investor knowledge bases), category, freshness (≤36h preferred), bilingual completeness, source authority. Items rated High or Medium enter the daily briefing pool — top 5 each for Economy and Crypto.
AI Roundtable
Independent takes from your chosen investors
Pick the investors below — each one analyzes this story through their own mental models, independently.
Pick the investors to invite
Choose 2–5 investors. We've pre-selected the ones whose expertise matches this story.
* AI simulates each investor's thinking based on public material — for learning reference only, not investment advice.